Mapol Inc. is pleased to welcome Lara Dangourian to the Mapol Team. Lara’s role is Manager, Market Access. Lara has over eight years of experience in the pharmaceutical industry. Her experience with HTA submissions and her detailed knowledge of processes will provide value to Mapol's clients in the preparation of new product submissions (or re-submissions). Based in Montréal, Lara will be supporting brand pharmaceutical manufactures within a wide range of market access activities. Lara holds a Master of Science degree in Drug Development from Université de Montréal.
TORONTO, Dec. 22, 2015 /CNW/ - In 2014 the cost of covering highly expensive and recurring drug treatments increased by 45% over 2013 for life and health insurance industry benefit plans. This information was released today by the Canadian Drug Insurance Pooling Corporation (CDIPC), the mechanism under which Canadian life and health insurers voluntarily share the costs of highly expensive and recurring drug treatments. Read More
To register, please email Sue-Lee at email@example.com with your name, company name and address and indicate which location you would like to attend.
Toronto - Monday, October 19, 2015 8:00 AM - 3:30 PM (Eastern Time)
Map and Directions
Montreal - Thursday, October 22, 2015 8:00 AM - 3:30 PM (Eastern Time)
Map and Directions
Final Speaker List and Topics:
This web video is designed specifically for brand pharmaceutical manufacturers who are interested in the contract renewal discussions between employers and benefits advisors. Hugh Paton, an experienced benefits advisor, will share first-hand experience about what is important to employers when they negotiate their benefits plan renewal contracts.Two role playing scenarios will be showcased:
- Insured Group Benefits Contract Renewal - features the interaction between an Employer and its Group Benefits Insurance Broker.
- Self-Insured (ASO) Benefits Contract Renewal - features an interaction between an Employer and its Third Party Administrator (TPA).
This offer is valid until .
1st Annual Benefits Advisors' Drug Plan Outlook Article: Drug Plan Issues Require Mutual Solutions
In partnership with Benefits and Pensions Monitor, Mapol brought together benefits advisors from across Canada with representatives of Canada’s brand pharmaceutical manufacturers on December 11, 2014 in Toronto to identify key developments in the benefits industry as they pertain to drug plans and to formulate recommendations for finding mutual solutions that will guide plan sponsors with group benefits and plan designs.
Mapol's 2nd Benefits Advisors’ Drug Plan Outlook Meeting will be held on November 26, 2015 in Downtown Toronto. For information on sponsorship opportunities, please contact Corinne Razem at firstname.lastname@example.org